Literature DB >> 21499803

Reduction of Poisson noise in measured time-resolved data for time-domain diffuse optical tomography.

S Okawa1, Y Endo, Y Hoshi, Y Yamada.   

Abstract

A method to reduce noise for time-domain diffuse optical tomography (DOT) is proposed. Poisson noise which contaminates time-resolved photon counting data is reduced by use of maximum a posteriori estimation. The noise-free data are modeled as a Markov random process, and the measured time-resolved data are assumed as Poisson distributed random variables. The posterior probability of the occurrence of the noise-free data is formulated. By maximizing the probability, the noise-free data are estimated, and the Poisson noise is reduced as a result. The performances of the Poisson noise reduction are demonstrated in some experiments of the image reconstruction of time-domain DOT. In simulations, the proposed method reduces the relative error between the noise-free and noisy data to about one thirtieth, and the reconstructed DOT image was smoothed by the proposed noise reduction. The variance of the reconstructed absorption coefficients decreased by 22% in a phantom experiment. The quality of DOT, which can be applied to breast cancer screening etc., is improved by the proposed noise reduction.

Entities:  

Mesh:

Year:  2011        PMID: 21499803     DOI: 10.1007/s11517-011-0774-7

Source DB:  PubMed          Journal:  Med Biol Eng Comput        ISSN: 0140-0118            Impact factor:   2.602


  14 in total

Review 1.  Developments toward diagnostic breast cancer imaging using near-infrared optical measurements and fluorescent contrast agents.

Authors:  D J Hawrysz; E M Sevick-Muraca
Journal:  Neoplasia       Date:  2000 Sep-Oct       Impact factor: 5.715

2.  Three-dimensional time-resolved optical tomography of a conical breast phantom.

Authors:  J C Hebden; H Veenstra; H Dehghani; E M Hillman; M Schweiger; S R Arridge; D T Delpy
Journal:  Appl Opt       Date:  2001-07-01       Impact factor: 1.980

3.  Three-dimensional optical tomography of the premature infant brain.

Authors:  Jeremy C Hebden; Adam Gibson; Rozarina Md Yusof; Nick Everdell; Elizabeth M C Hillman; David T Delpy; Simon R Arridge; Topun Austin; Judith H Meek; John S Wyatt
Journal:  Phys Med Biol       Date:  2002-12-07       Impact factor: 3.609

4.  Analysis of lesion detectability in Bayesian emission reconstruction with nonstationary object variability.

Authors:  Jinyi Qi
Journal:  IEEE Trans Med Imaging       Date:  2004-03       Impact factor: 10.048

5.  Quantitative spectroscopic diffuse optical tomography of the breast guided by imperfect a priori structural information.

Authors:  Gregory Boverman; Eric L Miller; Ang Li; Quan Zhang; Tina Chaves; Dana H Brooks; David A Boas
Journal:  Phys Med Biol       Date:  2005-08-11       Impact factor: 3.609

6.  Reduction of noise from magnetoencephalography data.

Authors:  S Okawa; S Honda
Journal:  Med Biol Eng Comput       Date:  2005-09       Impact factor: 2.602

7.  Time-domain scanning optical mammography: I. Recording and assessment of mammograms of 154 patients.

Authors:  Dirk Grosenick; K Thomas Moesta; Michael Möller; Jörg Mucke; Heidrun Wabnitz; Bernd Gebauer; Christian Stroszczynski; Bernhard Wassermann; Peter M Schlag; Herbert Rinneberg
Journal:  Phys Med Biol       Date:  2005-05-18       Impact factor: 3.609

8.  Time-domain scanning optical mammography: II. Optical properties and tissue parameters of 87 carcinomas.

Authors:  Dirk Grosenick; Heidrun Wabnitz; K Thomas Moesta; Jörg Mucke; Peter M Schlag; Herbert Rinneberg
Journal:  Phys Med Biol       Date:  2005-05-18       Impact factor: 3.609

9.  Optical tomography of the breast using a multi-channel time-resolved imager.

Authors:  Tara Yates; Jeremy C Hebden; Adam Gibson; Nick Everdell; Simon R Arridge; Michael Douek
Journal:  Phys Med Biol       Date:  2005-05-18       Impact factor: 3.609

10.  Development of a time-domain optical mammograph and first in vivo applications.

Authors:  D Grosenick; H Wabnitz; H H Rinneberg; K T Moesta; P M Schlag
Journal:  Appl Opt       Date:  1999-05-01       Impact factor: 1.980

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.